AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 151 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $459,000 | +1175.0% | 638,600 | +3935.9% | 0.01% | +1000.0% |
| Q4 2021 | $36,000 | -83.4% | 15,823 | -79.0% | 0.00% | -83.3% |
| Q3 2021 | $217,000 | +13.0% | 75,240 | +48.2% | 0.01% | 0.0% |
| Q2 2021 | $192,000 | +65.5% | 50,772 | +48.0% | 0.01% | +50.0% |
| Q1 2021 | $116,000 | +114.8% | 34,302 | +77.4% | 0.00% | +100.0% |
| Q4 2020 | $54,000 | +3.8% | 19,332 | -6.2% | 0.00% | -33.3% |
| Q3 2020 | $52,000 | -81.3% | 20,620 | -71.0% | 0.00% | -88.0% |
| Q3 2019 | $278,000 | -67.4% | 71,000 | -31.7% | 0.02% | -69.9% |
| Q1 2019 | $852,000 | +134.1% | 104,000 | +57.9% | 0.08% | +56.6% |
| Q4 2018 | $364,000 | – | 65,852 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $1,471,000 | 1.42% |
| Orchard Capital Management, LLC | 251,826 | $80,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 486,568 | $154,000 | 0.02% |
| Icon Wealth Advisors, LLC | 400,132 | $127 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 7,483,053 | $2,365,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,042,816 | $646,000 | 0.01% |
| WIPFLI FINANCIAL ADVISORS LLC, | 200,000 | $63,000 | 0.00% |
| WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
| James J. Burns & Company, LLC | 25,142 | $8,000 | 0.00% |
| Bayesian Capital Management, LP | 68,600 | $22,000 | 0.00% |